Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Sep
17
2021
Obviousness Of Method Claim Requires Expectation of Success for Recited Purpose Foley & Lardner LLP
May
6
2015
Federal Circuit Keeps Sandoz Biosimilar Off The Market For Now Foley & Lardner LLP
Feb
18
2022
Use of the “Hecho en México”® (Made in Mexico) Trademark and Logo Foley & Lardner LLP
Jun
2
2015
FTC’s $1.2 Billion Disgorgement Settlement With Cephalon: Heightened Scrutiny of Hatch-Waxman Settlements Foley & Lardner LLP
Sep
20
2017
Celgene Notches Rare Win On PTAB Request For Rehearing Foley & Lardner LLP
Sep
25
2017
USPTO Update on Patent-Eligibility for Life Science Inventions Foley & Lardner LLP
Jul
19
2022
A Third Surge in Innovation and Patents on Hydrogen Fuel Cell Vehicles Foley & Lardner LLP
Aug
24
2015
Protecting Diagnostic Innovation – Two Actor Infringement Liability Foley & Lardner LLP
Oct
4
2022
USPTO Extends Patents 4 Patients Program Foley & Lardner LLP
Sep
15
2015
Improving Patent Quality With International Collaborative Search Pilot Programs Foley & Lardner LLP
Mar
20
2018
An Economic Test For Patent Eligibility? Foley & Lardner LLP
Apr
24
2018
Supreme Court Upholds Constitutionality Of IPRs In Oil States Foley & Lardner LLP
Feb
1
2023
EPO and IEA Release Hydrogen Patent Report Showing Automotive Sector Plays a Key Role in Innovation Foley & Lardner LLP
Mar
27
2023
IP Lawyer vs. ChatGPT: Top 10 Legal Issues of Using Generative AI at Work Foley & Lardner LLP
Aug
16
2018
Restoring America’s Leadership in Innovation Act of 2018 Foley & Lardner LLP
May
1
2023
Another Letter From Congress Complaining About Pharmaceutical Patents Foley & Lardner LLP
Oct
1
2018
Insurers Must Pay Cost of Defending Case Stemming from Use of Famous Marathoner’s Name Foley & Lardner LLP
May
16
2023
Supreme Court Won’t Hear Skinny Label Case Foley & Lardner LLP
Dec
17
2015
Federal Circuit Affirms PTAB's IPR Decision Invalidating A Pharmaceutical Patent Foley & Lardner LLP
Oct
26
2018
USPTO Announces Proposal To Facilitate Amendments In AIA Challenges Foley & Lardner LLP
Nov
27
2018
District Court Finds PK Targets Of VIMOVO Patents Indefinite Foley & Lardner LLP
Dec
30
2015
Use of Priority Denial to Subject Apparent "Pre-AIA" Patents to PGR: Inguran v. Premium Genetics Foley & Lardner LLP
Jan
19
2016
PTAB Denies Challenge Of Abbvie Humira Patents Foley & Lardner LLP
Jan
7
2019
New USPTO Guidance on Patent Subject Matter Eligibility Seeks to Standardize Abstract Idea Analysis Foley & Lardner LLP
Jan
29
2016
Split Federal Circuit Upholds Constitutionality of Single PTAB Panels Rendering Both Institution & Final Written Decisions Foley & Lardner LLP
Feb
11
2016
FDA Panel Shows Strong Support for Remicade Biosimilar Foley & Lardner LLP
Oct
16
2023
Growing Infringement of OEM IP Rights on Online Marketplaces Foley & Lardner LLP
Mar
15
2016
PTAB Institutes Kyle Bass IPR Against Pharmaceutical Patent Based On SEC Document Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins